| Daniel H Kelly, MD | |
|
2500 N State St, Jackson, MS 39216-4500 | |
| (601) 984-5607 | |
| (601) 984-6665 |
| Full Name | Daniel H Kelly |
|---|---|
| Gender | Male |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 2500 N State St, Jackson, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417480831 | NPI | - | NPPES |
| Entity Name | Medical Foundation Of Central Mississippi Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992774814 PECOS PAC ID: 1153216411 Enrollment ID: O20040217000380 |
News Archive
Ultrasound-guided cortisone injections may be an effective treatment method for gluteus medius tendinopathy, a common, painful condition caused by an injury to the tendons in the buttocks that typically affects middle-aged to elderly women and young active individuals, according to a study published in the January issue of the American Journal of Roentgenology.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Ovarian cancer survivors, their friends and families, local businesses, corporate teams and employees of The University of Texas MD Anderson Cancer Center will join forces May 5 at the 15th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run. The approximately 3,000 participants will come together for a common cause: to build awareness of ovarian cancer and raise funds for research.
Baxter International Inc. today announced data featuring ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], a leading recombinant treatment available worldwide, during the 24th Annual Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Amsterdam, The Netherlands.
Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.
› Verified 4 days ago
| Entity Name | Mississippi Baptist Medical Center, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467589556 PECOS PAC ID: 9234026600 Enrollment ID: O20110707000181 |
News Archive
Ultrasound-guided cortisone injections may be an effective treatment method for gluteus medius tendinopathy, a common, painful condition caused by an injury to the tendons in the buttocks that typically affects middle-aged to elderly women and young active individuals, according to a study published in the January issue of the American Journal of Roentgenology.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Ovarian cancer survivors, their friends and families, local businesses, corporate teams and employees of The University of Texas MD Anderson Cancer Center will join forces May 5 at the 15th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run. The approximately 3,000 participants will come together for a common cause: to build awareness of ovarian cancer and raise funds for research.
Baxter International Inc. today announced data featuring ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], a leading recombinant treatment available worldwide, during the 24th Annual Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Amsterdam, The Netherlands.
Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel H Kelly, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5607 | Daniel H Kelly, MD 2500 N State St, Jackson, MS 39216-4500 Ph: (601) 984-5607 |
News Archive
Ultrasound-guided cortisone injections may be an effective treatment method for gluteus medius tendinopathy, a common, painful condition caused by an injury to the tendons in the buttocks that typically affects middle-aged to elderly women and young active individuals, according to a study published in the January issue of the American Journal of Roentgenology.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Ovarian cancer survivors, their friends and families, local businesses, corporate teams and employees of The University of Texas MD Anderson Cancer Center will join forces May 5 at the 15th annual Sprint for Life 5K Run/Walk and Sprint for Sprouts Kids' Run. The approximately 3,000 participants will come together for a common cause: to build awareness of ovarian cancer and raise funds for research.
Baxter International Inc. today announced data featuring ADVATE [Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method], a leading recombinant treatment available worldwide, during the 24th Annual Congress of the International Society on Thrombosis and Haemostasis (ISTH) in Amsterdam, The Netherlands.
Today's early morning highlights from the major news organizations, including news stories about healthcare.gov management changes.
› Verified 4 days ago